Amway, an entrepreneur-led health and wellness company, today reported sales of $8.1 billion USD for the year ending December 31, 2022. This represents an overall decline from 2021 sales of $8.9 billion due to the strength of the US dollar, the sale of Metagenics, Inc. (a non-direct selling entity), and the ceasing of operations in Russia.
On a constant currency basis, sales for Amway’s direct selling business were up 1.0% representing a third consecutive year of growth. This growth was driven by entrepreneurs all over the world who are dedicated to providing health and wellness solutions to their customers. Several of Amway’s top markets experienced growth in 2022 including Mainland China, South Korea, Hong Kong, Malaysia, Taiwan and Vietnam.
“For more than 60 years, Amway has focused on helping entrepreneurs build rewarding businesses by providing customers with health and wellness solutions that help them live better, healthier lives,”
said Amway Chief Executive Officer Milind Pant.
“Health and wellness is infused in everything we do, which shows in our category sales.
In 2022, our Nutrilite™ brand accounted for more than 50 percent of global sales, representing growth of eight percent for the Nutrition category. In addition, our healthy beauty category, featuring Artistry™ skincare and